Hair Loss and Elevated Eosinophils: Diagnostic Approach
Hair loss with elevated eosinophils most commonly indicates hypereosinophilic syndrome (HES) when other causes are excluded, requiring urgent evaluation for end-organ damage and immediate corticosteroid therapy if confirmed. 1
Initial Risk Stratification
The absolute eosinophil count (AEC) determines urgency and diagnostic approach:
- Mild eosinophilia (0.5-1.5 × 10⁹/L): Most commonly caused by allergic disorders or medications in non-endemic areas, but helminth infections account for 19-80% in returning travelers 2
- Moderate-to-severe eosinophilia (≥1.5 × 10⁹/L): Requires hematology referral if persisting >3 months after infectious causes excluded 2
- Hypereosinophilia (≥1.5 × 10⁹/L): Demands immediate evaluation for end-organ damage regardless of symptoms 3, 2
Critical Red Flags Requiring Urgent Assessment
Evaluate immediately for life-threatening complications:
- Cardiac involvement: Chest pain, dyspnea, heart failure symptoms, or arrhythmias suggest endomyocardial thrombosis/fibrosis, particularly with neoplastic HES variants 3, 2
- Neurological symptoms: Altered mental status, focal deficits, or peripheral neuropathy indicate CNS/spinal cord involvement 3, 2
- Pulmonary involvement: Persistent cough, wheezing, or infiltrates on imaging 3, 2
Systematic Diagnostic Workup
Step 1: Exclude Secondary Causes (Most Common)
Allergic disorders account for ~80% of secondary eosinophilia 3:
- Atopic dermatitis, allergic rhinitis, asthma, drug reactions
- Note: Alopecia areata (AA) patients with concurrent eosinophilia have 3.70 times higher odds of severe hair loss and increased nail abnormalities compared to AA without eosinophilia 4
Parasitic infections (second most common cause) 3:
- Obtain detailed travel history: fresh water exposure in Africa/tropical regions, raw/undercooked meat consumption 2
- Order 3 separate concentrated stool specimens for ova/parasites 2
- Send Strongyloides and Schistosoma serology based on exposure history 2
- Critical: Strongyloides can persist lifelong and cause fatal hyperinfection in immunocompromised patients 2
Medication reactions: Review all current and recent medications 5
Step 2: Assess for End-Organ Damage
Mandatory cardiac evaluation for AEC ≥1.5 × 10⁹/L 2:
- ECG, cardiac troponin, NT-proBNP
- Echocardiography if troponin elevated or cardiac symptoms present
- Cardiac MRI to distinguish eosinophilic cardiac disease from other etiologies
Dermatologic assessment (directly relevant to hair loss):
- Deep skin biopsy including fascia to document eosinophilic infiltration 2
- Scalp biopsy showing dense perifollicular eosinophilic infiltration confirms HES-related alopecia 1
Additional organ systems 3, 2:
- Pulmonary: Chest X-ray, pulmonary function tests if respiratory symptoms
- GI: Endoscopy with biopsies if dysphagia, diarrhea, or abdominal pain
- Neurologic: EMG and nerve biopsy if peripheral neuropathy suspected
Step 3: Rule Out Myeloproliferative/Lymphocytic Variants
If secondary causes excluded and hypereosinophilia persists 3:
- Bone marrow biopsy with cytogenetics
- Test for FIP1L1-PDGFRA fusion gene (responds to imatinib)
- Flow cytometry to exclude lymphocytic variant HES
- Serum tryptase and vitamin B12 (elevated in myeloproliferative variants)
Treatment Algorithm
For Confirmed Hypereosinophilic Syndrome with Hair Loss
Immediate corticosteroid therapy is first-line 1, 6:
- Oral prednisone 1 mg/kg/day initially
- Effective for reducing both hair loss and blood eosinophilia
- Critical caveat: Relapse is common after discontinuation, requiring long-term maintenance 1
For Parasitic Infections
Empiric treatment while awaiting results in endemic-exposed patients 2:
- Ivermectin 200 μg/kg daily for 2 days (Strongyloides)
- Albendazole 400 mg twice daily for 3 days (Ascaris, hookworm)
- Praziquantel 40 mg/kg single dose for Schistosomiasis
Critical warning for Loa loa: Do NOT use diethylcarbamazine if microfilariae seen on blood film—may cause fatal encephalopathy; use corticosteroids with albendazole first 2
For Myeloproliferative Variants
Imatinib 100-400 mg daily for FIP1L1-PDGFRA-positive cases 3
Common Pitfalls to Avoid
- Do not assume allergy alone explains hypereosinophilia (≥1.5 × 10⁹/L)—this level is rarely if ever caused by allergy and demands full workup 5, 6
- Do not rely on symptoms alone to assess organ damage—cardiac involvement can be subclinical initially 2
- Do not assume normal eosinophil count excludes parasites—many helminth-infected patients have normal counts 2
- Do not delay cardiac evaluation in moderate-to-severe eosinophilia—endomyocardial fibrosis can develop rapidly 3, 2
- Do not start corticosteroids before excluding Strongyloides in at-risk patients—can precipitate fatal hyperinfection 2
Prognosis and Monitoring
For HES-related diffuse alopecia with massive perifollicular eosinophils 1:
- Corticosteroids effectively reduce hair loss and eosinophilia
- Immediate relapse typical after treatment cessation
- Long-term maintenance therapy required
- Regular monitoring of AEC and organ function essential